Recommendations on stroke prevention for patients having a CHA(2)DS(2)-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines

Chao Tze-Fan; Chen Shih-Ann; Lip Gregory Y. H.

首页> 外文期刊>Trends in Cardiovascular Medicine >Recommendations on stroke prevention for patients having a CHA(2)DS(2)-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines

【24h】

Recommendations on stroke prevention for patients having a CHA(2)DS(2)-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines

机译：关于2019年心房颤动指南的患者患有CHA（2）DS（2）DS（2）DS（2）DS（2）的患者的卒中预防的建议

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Trends in Cardiovascular Medicine》 |2019年第7期|共2页
作者
Chao Tze-Fan; Chen Shih-Ann; Lip Gregory Y. H.;
展开▼
作者单位

Taipei Vet Gen Hosp Dept Med Div Cardiol 201 Sec 2 Shih Pai Rd Taipei Taiwan;

Taipei Vet Gen Hosp Dept Med Div Cardiol 201 Sec 2 Shih Pai Rd Taipei Taiwan;

Univ Liverpool Liverpool Ctr Cardiovasc Sci Liverpool Merseyside England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Recommendations on stroke prevention for patients having a CHA(2)DS(2)-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines [J] . Chao Tze-Fan, Chen Shih-Ann, Lip Gregory Y. H. Trends in Cardiovascular Medicine . 2019,第7期

机译：关于2019年心房颤动指南的患者患有CHA（2）DS（2）DS（2）DS（2）DS（2）的患者的卒中预防的建议
2. Letter by Asinger et al Regarding Articles, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA(2)DS(2)-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke" and "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA(2)DS(2)-VASc Score 1 in Men, 2 in Women) Be Anticoagulated?: The CHA(2)DS(2)-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum" [J] . Asinger Richard W., Shroff Gautam R., Herzog Charles A. Circulation: An Official Journal of the American Heart Association . 2016,第18期

机译：Asinger等人关于文章的信，“房颤和1个中风危险因素（CHA（2）DS（2）-VASc男性得分1，女性2分）的患者应抗凝吗？是：甚至有1个中风危险因子发生中风的真正风险”和“应将具有房颤和1个中风危险因素（CHA（2）DS（2）-VASc男性为1，女性为2）的患者抗凝治疗吗？：CHA（2）DS（2 ）-VASc 1难题：风险范围较低端的决策”
3. Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA(2)DS(2)-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially 'Low-Risk' Patients [J] . Chao Tze-Fan, Liao Jo-Nan, Tuan Ta-Chuan, Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis . 2019,第7期

机译：故事的患者在心房颤动的患者中，最初用CHA（2）DS（2）-VASC评分为0（男性）或1（女性）：在最初的“低风险”患者中对卒中风险重新评估的影响
4. Early Experiences from a Guideline-based Computerized Clinical Decision Support for Stroke Prevention in Atrial Fibrillation [C] . Rong Chen, Carlos Vailadares, Iago Corbal, MEDINFO . 2013

机译：基于指南的计算机化临床决策支持的早期经验支持心房颤动中的中风预防
5. Cost effectiveness of warfarin in anticoagulant clinic after introduction of dabigatran for stroke prevention in atrial fibrillation patients in the United States [D] . Alhazami, Mai S. 2015

机译：在美国引入达比加群后预防心房颤动患者中风后华法林在抗凝临床中的成本效益
6. Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS2 and CHA2DS2-VASc score levels and warfarin prescription for adult patients with atrial fibrillation [O] . Scott A. Chapman, Catherine A. St Hill, Meg M. Little, 2017

机译：遵守治疗指南：成人房颤患者卒中风险分层比较CHADS2和CHA2DS2-VASc评分水平与华法林处方之间的关联
7. Response by Halperin and Savino to Letter Regarding Article, “Should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA 2 DS 2 -VASc Score 1 in Men, 2 in Women) Be Anticoagulated? The CHA 2 DS 2 -VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum” [O] . Jonathan L. Halperin, John A. Savino 2016

机译：Halperin和Savino对文章的回应，“如果心房颤动的患者和1次卒中危险因素（CHA 2 DS 2 -vasc评分1中男性，女性，女性2人）是抗癌的吗？ CHA 2 DS 2 -VASC 1难题：在风险谱的下端决策“

Recommendations on stroke prevention for patients having a CHA(2)DS(2)-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines

著录项

相似文献

相关主题

期刊订阅